Title Description

US

Tolvaptan API process
Ref. Number: US9428461B2
(dtd. 30 Dec, 2016)
Patent application no.
US 2015/O112059A1
(dtd.20 Dec, 2014)
Clopidogrel Free base process
Ref. Number: US8063217B2
(dtd. 22 Dec, 2011)
Patent application no.
US 201O/OOO4453A1
(dtd.20 Dec, 2007)

India

Tolvaptan (API)Intermediate
Ref. Number: 304391
(dtd. 13 Dec, 2018)
Patent application no.
3295/MUM/2013
(dtd.21 Dec, 2013)
Clopidogrel Bisulphate form 1 API process
Ref. Number: 298954
(dtd. 18 Dec, 2018)
Patent application no.
758/MUM/2010
(dtd.22 Dec, 2010)
S(+) clopidogrel free base process
Ref. Number: 252835
(dtd. 04 Dec, 2012)
Patent application no.
836/MUM/2005
(dtd.12 Dec, 2005)
Pantoprazole sodium sesquihydrate API process
Ref. Number: 238641
(dtd. 15 Dec, 2010)
Patent application no.
551/MUM/2005
(dtd.04 Dec, 2005)
Lamotrigine Dispersible & Meltable Tablet process
Ref. Number: 219025
(dtd. 21 Dec, 2008)
Patent application no.
419/MUM/2004
(dtd.06 Dec, 2004)
Cyclosporine formulation process
Ref. Number: 203188
(dtd. 07 Dec, 2006)
Patent application no.
254/MUMNP/2003
(dtd.24 Dec, 2003)
Risperidon API process
Ref. Number: 196155
(dtd. 04 Dec, 2005)
Patent application no.
IN/PCT/2002/01520/MUM
(dtd.30 Dec, 2002)